These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1770156

  • 1. Rebound insomnia: duration of use and individual differences.
    Merlotti L, Roehrs T, Zorick F, Roth T.
    J Clin Psychopharmacol; 1991 Dec; 11(6):368-73. PubMed ID: 1770156
    [Abstract] [Full Text] [Related]

  • 2. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI.
    N Engl J Med; 1987 Sep 17; 317(12):722-8. PubMed ID: 3306380
    [Abstract] [Full Text] [Related]

  • 3. Rebound insomnia: a critical review.
    Gillin JC, Spinweber CL, Johnson LC.
    J Clin Psychopharmacol; 1989 Jun 17; 9(3):161-72. PubMed ID: 2567741
    [Abstract] [Full Text] [Related]

  • 4. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB.
    J Clin Psychiatry; 1993 Jan 17; 54(1):33-8. PubMed ID: 8428895
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA, McClure DJ, Mayes C, Phillips R, Bourgouin J.
    Int Clin Psychopharmacol; 1990 Apr 17; 5 Suppl 2():29-37. PubMed ID: 2201728
    [Abstract] [Full Text] [Related]

  • 6. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.
    Pharmacopsychiatry; 1994 Jul 17; 27(4):166-75. PubMed ID: 7972349
    [Abstract] [Full Text] [Related]

  • 7. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J, Ruel D, Maillard F, Bianchi M.
    Int Clin Psychopharmacol; 1990 Apr 17; 5 Suppl 2():47-55. PubMed ID: 2201730
    [Abstract] [Full Text] [Related]

  • 8. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM, Seidel WF, van den Hoed J, Greenblatt DJ, Dement WC.
    J Clin Psychopharmacol; 1984 Feb 17; 4(1):2-13. PubMed ID: 6141188
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 17; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 10. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
    Roehrs T, Merlotti L, Zorick F, Roth T.
    Psychopharmacology (Berl); 1992 Aug 17; 108(1-2):67-71. PubMed ID: 1410148
    [Abstract] [Full Text] [Related]

  • 11. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H, Feige B, Cloot O, Van Wasen H, Zinzgraf D, Hohagen F, Riemann D.
    Pharmacopsychiatry; 2004 Sep 17; 37(5):228-35. PubMed ID: 15359376
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun 17; 251(3):117-23. PubMed ID: 11697572
    [Abstract] [Full Text] [Related]

  • 13. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG.
    Clin Neuropharmacol; 2008 Jun 17; 31(1):40-50. PubMed ID: 18303490
    [Abstract] [Full Text] [Related]

  • 14. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B.
    Pharmacopsychiatry; 1987 May 17; 20(3):116-9. PubMed ID: 2885865
    [Abstract] [Full Text] [Related]

  • 15. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
    Pecknold J, Wilson R, le Morvan P.
    Int Clin Psychopharmacol; 1990 Apr 17; 5 Suppl 2():57-67. PubMed ID: 2117623
    [Abstract] [Full Text] [Related]

  • 16. Nighttime versus daytime hypnotic self-administration.
    Roehrs T, Bonahoom A, Pedrosi B, Zorick F, Roth T.
    Psychopharmacology (Berl); 2002 May 17; 161(2):137-42. PubMed ID: 11981593
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    Elie R, Frenay M, Le Morvan P, Bourgouin J.
    Int Clin Psychopharmacol; 1990 Apr 17; 5 Suppl 2():39-46. PubMed ID: 2201729
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.
    Hegelbach-Feller DA, Tschopp JM, Christeller S, Fabre J.
    Arzneimittelforschung; 1988 Mar 17; 38(3):387-92. PubMed ID: 3289550
    [Abstract] [Full Text] [Related]

  • 19. Dose determinants of rebound insomnia.
    Roehrs TA, Zorick FJ, Wittig RM, Roth T.
    Br J Clin Pharmacol; 1986 Aug 17; 22(2):143-7. PubMed ID: 3530302
    [Abstract] [Full Text] [Related]

  • 20. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines.
    Kales A, Manfredi RL, Vgontzas AN, Bixler EO, Vela-Bueno A, Fee EC.
    Clin Pharmacol Ther; 1991 Apr 17; 49(4):468-76. PubMed ID: 2015735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.